Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | |
| Sales | 10,355 | 0 | 0 |
| Cost of Goods | 1,180 | N/A | N/A |
| Gross Profit | 9,175 | N/A | N/A |
| Operating Expenses | 80,405 | 29,209 | 27,043 |
| Operating Income | -71,050 | -29,209 | -27,043 |
| Interest Expense | 1,876 | 1,232 | 156 |
| Other Income | 644 | 486 | 9 |
| Pre-tax Income | -72,282 | -29,955 | -27,190 |
| Net Income Continuous | -72,282 | -29,955 | -27,190 |
| Net Income | $-72,282 | $-29,955 | $-27,190 |
| EPS Basic Total Ops | -2.60 | -1.40 | -1.57 |
| EPS Basic Continuous Ops | -2.60 | -1.40 | -1.57 |
| EPS Diluted Total Ops | -2.60 | -1.40 | -1.57 |
| EPS Diluted Continuous Ops | -2.60 | -1.40 | -1.57 |
| EPS Diluted Before Non-Recurring Items | -2.60 | N/A | N/A |
| EBITDA(a) | $-70,372 | $-29,209 | $-27,043 |